Isolation and identification of SARS-CoV-2 antibodies from COVID-19 patient samples
<p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causing agent for COVID-19, has led to over 7 million deaths since it was first detected in Wuhan, China in December 2019. Antibodies induced by both vaccination and infection are crucial for the immune protection ag...
Yazar: | Liu, C |
---|---|
Diğer Yazarlar: | Screaton, GR |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
2024
|
Konular: |
Benzer Materyaller
-
SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract
Yazar:: Alba Escalera, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01) -
Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection
Yazar:: Xiao-Lin Jiang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01) -
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2
Yazar:: Cyril Planchais, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01) -
SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
Yazar:: Jeewandara, C, ve diğerleri
Baskı/Yayın Bilgisi: (2021) -
Cross-reactive immunity to SARS-CoV-2 and related coronaviruses
Yazar:: Jay, C
Baskı/Yayın Bilgisi: (2023)